A comprehensive analysis of constitutive naturally processed and presented HLA-C*04:01 (Cw4)-specific peptides

Autor: R B, Schittenhelm, N L, Dudek, N P, Croft, S H, Ramarathinam, A W, Purcell

Publikováno v: Tissue Antigens

The human B lymphoblastoid cell line C1R is widely regarded as human leukocyte antigen-A (HLA-A)/HLA-B negative and is therefore frequently exploited as a recipient cell line to study HLA class I functions. However, the normal levels of HLA-C*04:01 o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f275d00e4d2023daecb941f109b8ff78

Hypoxic pulmonary vasoconstriction does not limit maximal exercise capacity in healthy volunteers breathing 12% oxygen at sea level.

Autor: Talbot, Nick P.¹ (AUTHOR) nick.talbot@dpag.ox.ac.uk, Cheng, Hung‐Yuan² (AUTHOR), Hanstock, Helen³ (AUTHOR), Smith, Thomas G.^4,5 (AUTHOR), Dorrington, Keith L.¹ (AUTHOR), Robbins, Peter A.¹ (AUTHOR)

Publikováno v: Physiological Reports. Feb2024, Vol. 12 Issue 4, p1-13. 13p.

mRNA‐based Vaccines Targeting the T‐cell Epitope‐rich Domain of Epstein Barr Virus Latent Proteins Elicit Robust Anti‐Tumor Immunity in Mice.

Autor: Zhao, Ge‐Xin¹ (AUTHOR), Bu, Guo‐Long¹ (AUTHOR), Liu, Gang‐Feng² (AUTHOR), Kong, Xiang‐Wei¹ (AUTHOR), Sun, Cong¹ (AUTHOR), Li, Zi‐Qian¹ (AUTHOR), Dai, Dan‐Ling¹ (AUTHOR), Sun, Hai‐Xia¹ (AUTHOR), Kang, Yin‐Feng¹ (AUTHOR), Feng, Guo‐Kai¹ (AUTHOR) fengguok@sysucc.org.cn, Zhong, Qian¹ (AUTHOR) zhongqian@sysucc.org.cn, Zeng, Mu‐Sheng^1,3 (AUTHOR) zengmsh@sysucc.org.cn

Publikováno v: Advanced Science. Dec2023, Vol. 10 Issue 35, p1-15. 15p.

Peptide Presentation to T Cells: Solving the Immunogenic Puzzle: Systems Immunology Profiling of Antigen Presentation for Prediction of CD8⁺ T Cell Immunogenicity.

Autor: Croft, Nathan P.

Publikováno v: BioEssays; Mar2020, Vol. 42 Issue 3, p1-9, 9p

Intranasal Delivery of Pure Nanodrug Loaded Liposomes for Alzheimer's Disease Treatment by Efficiently Regulating Microglial Polarization.

Autor: Feng Q; School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, 450001, P. R. China.; Henan Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou, 450001, P. R. China., Zhang X; School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, 450001, P. R. China., Zhao X; School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, 450001, P. R. China., Liu J; School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, 450001, P. R. China., Wang Q; School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, 450001, P. R. China., Yao Y; School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, 450001, P. R. China., Xiao H; Department of Pharmacy, Henan General Hospital, Zhengzhou, 450002, P. R. China., Zhu Y; School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, 450001, P. R. China., Zhang W; School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, 450001, P. R. China., Wang L; School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, 450001, P. R. China.; Henan Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou, 450001, P. R. China.

Publikováno v: Small (Weinheim an der Bergstrasse, Germany) [Small] 2024 Dec; Vol. 20 (50), pp. e2405781. Date of Electronic Publication: 2024 Oct 06.